4Filing Date: Aug 28, 2026
Edwards Lifesciences (EW)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001225208-26-007377
Total Value$237.9K
Trades1
Insiders1
Transaction Details
Bruls Annette
CVP, EMEACLA·Direct
Sell · Dispose
Common Stock
Shares-2.64K
Price$89.98
Total Value$237.9K
Shares Owned After17.98K
Transaction DateAug 28, 2026
Post-Transaction Holdings
Bruls Annette · CVP, EMEACLA
| Security | Shares | Change |
|---|---|---|
| Common Stock | 17.98K | -2.64K (-12.82%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-08-28
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Bruls Annette
CIK: 0002032351
Role: Officer (CVP, EMEACLA)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-08-28 | Code: S (Open market sale)
Shares: -2,644 | Price: $89.98
Total Value: $237,907.12
Shares Owned After: 17,984 | Ownership: D (Direct)
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-08-28)